Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Reexamination Certificate
2000-12-18
2008-09-23
Mosher, Mary E (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
C530S326000, C530S325000, C530S324000, C530S350000, C530S402000, C435S320100, C435S348000, C435S252300, C536S023400, C424S178100, C424S186100
Reexamination Certificate
active
07427658
ABSTRACT:
The coding information for three putative chicken anemia virus proteins (VP1, VP2, VP3) was inserted into a baculovirus vector and expressed in insect cells. Only lysates of insect cells which have synthesized equivalent amounts of all three recombinant CAV proteins or cells which synthesized mainly VP1 plus VP2 induced neutralizing antibodies directed against CAV in inoculated chickens. Progeny of those chickens were protected against clinical disease after CAV challenge. Inoculation of a mixture of lysates of cells that were separately infected with VP1-, VP2- and VP3-recombinant baculovirus did not induce significant levels of neutralizing antibody directed against CAV and their progeny were not protected against CAV challenge. Expression in the same cell of at least VP1 plus VP2 is required to obtain sufficient protection in chickens. Therefore, recombinant CAV proteins produced by baculovirus vectors can be used as a sub-unit vaccine against CAV infections.
REFERENCES:
patent: 5554525 (1996-09-01), Sondermeijer
patent: 5952002 (1999-09-01), Noteborm et al.
patent: 6071520 (2000-06-01), Noteborn et al.
patent: 6162461 (2000-12-01), Noteborn et al.
patent: 6217870 (2001-04-01), Noteborn et al.
patent: 6238669 (2001-05-01), Noteborn et al.
patent: 6319693 (2001-11-01), Noteborn et al.
patent: 6509446 (2003-01-01), Noteborn et al.
patent: 0483911 (1992-05-01), None
patent: 0533294 (1993-03-01), None
Griffiths et al (Journal of Pathology 151:221-9, 1987, abstract only cited).
Wychowski et al., “The Intranuclear Location of Simian Virus 40 Polypeptides VP2 and VP3 Depends on a Specific Amino Acid Sequence,” Journal of Virology, vol. 61, No. 12. (1987).
Gelderbloom, et al, (1989)Archives of Virology109:115-120.
Jeurissen, et al, (1992)J Virology65:7383-7388.
Noteborn, et al (1991)J Virology65:3131-3139.
Noteborn, et al (1992)Avian Pathology21:107-118.
Noteborn, et al (1992)Gene118:267-271.
Noteborn, et al (1993)Vaccines 93, CSHL Press, Cold Spring Harbor, USA, pp. 299-304 Biosis accession No. 45092556.
Ramakrishnan, et al (1993)Nature362:217-223.
Todd, et al (1990)J General Virology71:819-823.
Todd, et al (1991)Archives of Virology117:129-135.
Dermer, G. (1994)Bio/Technology12:320.
Okin, et al (1995) “Report and Recommendations of the Panel to assess the NIH investment in Research on Gene Therapy”.
Meehan, et al (1992)Archives of Virology124:301-319.
Chandratilleke, et al (1991)Avian Diseases35:854-862.
Koch Guus
Noteborn Mathieu Hubertus Maria
Leadd B.V.
Mosher Mary E
LandOfFree
Chicken anemia virus mutants and vaccines and uses based on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chicken anemia virus mutants and vaccines and uses based on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chicken anemia virus mutants and vaccines and uses based on... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3982665